Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Giorgia Mancini"'
Autor:
Attilio Olivieri, Giorgia Mancini
Publikováno v:
Cells, Vol 13, Iss 18, p 1524 (2024)
Whereas aGVHD has strong inflammatory components, cGVHD displays autoimmune and fibrotic features; incidence and risk factors are similar but not identical; indeed, the aGVHD is the main risk factor for cGVHD. Calcineurin Inhibitors (CNI) with either
Externí odkaz:
https://doaj.org/article/3075998cfdd045a8a7c188fe8e06188d
Autor:
Giuseppe Tarantino, Francesco Saraceni, Giorgia Mancini, Monica Poiani, Luca Maroni, Gaia Goteri, Ilaria Scortechini, Alessandro Fiorentini, Maria Vittoria Dubbini, Francesco Marini, Luigi Daretti, Marco Marzioni, Emanuele Bendia, Antonio Benedetti, Attilio Olivieri
Publikováno v:
Clinical Hematology International, Vol 3, Iss 4 (2021)
Gastrointestinal complications (GICs) represent the major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Differential diagnosis of GICs is of paramount importance since early and reliable identi
Externí odkaz:
https://doaj.org/article/7d1ba0adf251420a90ba9f6a77a25c30
Autor:
Francesco Saraceni, Ilaria Scortechini, Alessandro Fiorentini, Maria Vittoria Dubbini, Giorgia Mancini, Irene Federici, Francesca Romana Colaneri, Antonio Federico Lotito, Selene Guerzoni, Bruna Puglisi, Attilio Olivieri
Publikováno v:
Clinical Hematology International, Vol 3, Iss 4 (2021)
Despite the recent dramatic progress in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) therapy, allogeneic transplant remains a mainstay of treatment for patients with acute leukemia. The availability of novel compounds and low i
Externí odkaz:
https://doaj.org/article/4060c439294e49b3a368371ad7c87f31
Autor:
Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Francesco Saraceni, Ilaria Scortechini, Giorgia Mancini, Alessandro Fiorentini, Attilio Olivieri, Massimo Offidani
Publikováno v:
Cells, Vol 11, Iss 4, p 606 (2022)
The introduction of high-dose therapy in the 1990s as well as the development of drugs such as thalidomide, lenalidomide, and bortezomib in the 2000s led to an impressive improvement in outcome of patients with multiple myeloma (MM) eligible for auto
Externí odkaz:
https://doaj.org/article/59b3707f633b4a73a6c85f504cf2589f
Autor:
Gianmarco Bastianoni, Leonardo Brugiatelli, Adelina Selimi, Giulia Stronati, Federico Paolini, Michele Alfieri, Sara Belleggia, Lorenzo Torselletti, Francesca Coraducci, Francesca Coretti, Samuele Principi, Alice Frangione, Edlira Rrapaj, Giorgia Mancini, Attilio Olivieri, Alessandro Barbarossa, Giuseppe Ciliberti, Antonio Dello Russo, Federico Guerra
Publikováno v:
European Heart Journal Supplements. 24
Introduction The mechanisms of cardiotoxicity during CAR-T cell therapy remain unclear to this day. We present the case of a 63-year-old woman with diffuse large B-cell lymphoma, who underwent CAR-T cell therapy. Five days after the infusion, she dev
Autor:
Maria Vittoria Dubbini, Ilaria Scortechini, Antonio Federico Lotito, Francesco Saraceni, Francesca Romana Colaneri, Giorgia Mancini, Selene Guerzoni, Alessandro Fiorentini, Irene Federici, Attilio Olivieri, Bruna Puglisi
Publikováno v:
Clinical Hematology International
Clinical Hematology International, Vol 3, Iss 4 (2021)
Clinical Hematology International, Vol 3, Iss 4 (2021)
Despite the recent dramatic progress in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) therapy, allogeneic transplant remains a mainstay of treatment for patients with acute leukemia. The availability of novel compounds and low i
Autor:
Elisa, Molinelli, Giorgia, Mancini, Valerio, Brisigotti, Claudia, Sapigni, Oriana, Simonetti, Attilio, Olivieri, Annamaria, Offidani
Publikováno v:
Journal of the American Academy of Dermatology. 87:1180-1181
Autor:
Monica Poiani, Irene Federici, Giuseppina Urbano, Ilaria Scortechini, Antonio Federico Lotito, Gabriele Polonara, Francesco Saraceni, Francesca Romana Colaneri, Elena Inglese, Giorgia Mancini, Attilio Olivieri
Publikováno v:
Bone Marrow Transplantation. 56:3081-3083
Autor:
Arnon Nagler, Massimo Martino, Francesca Bonifazi, Jacopo Olivieri, N. Di Renzo, Giorgia Mancini, Andrea Bacigalupo, E. Marinelli Busilacchi, Benedetto Bruno, Antonella Poloni, Francesco Onida, N. Mordini, Attilio Olivieri, Paolo Corradini, Roberta Nuccorini, Stefano Angelini, Michele Cimminiello, Fabio Ciceri, S. P. Pascale, Francesca Patriarca, Giovanni Grillo
Publikováno v:
Bone Marrow Transplantation. 55:2077-2086
We conducted a phase I-II study to evaluate Nilotinib (NIL) safety and pharmacokinetics in 22 SR-cGVHD patients; we also evaluated ORR by using in parallel NIH criteria and an exploratory approach, combining objective improvement (OI) without failure
Autor:
Francesco Saraceni, Patrizia Bagnarelli, Paolo Barbatelli, Irene Federici, Giorgia Mancini, Ilaria Scortechini, Marianna Mariani, Attilio Olivieri, Mariana Gaetani, Maria Luisa Minnucci
Publikováno v:
Transplant Infectious Disease
Graft‐versus‐host disease (GVHD) is a common complication of hematopoietic stem cell transplant, which is known to be mediated by cytotoxic T‐cell effectors and dysregulated inflammatory cytokines. Similarly, the lung injury observed in severe